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Buschke-Ollendorff syndrome (BOS; McKusick 16670) is 
~n autosomal dominant connective-tissue disorder character-
Ized by uneven osseous formation in bone (osteopoikilosis) 
and fibrous skin papules (dermatofibrosis lenticularis disse-
Ilunata). We describe two patients in whom BOS occurred in 
a.n autosomal dominant inheritance pattern. The connective 
tbsue of the skin lesions showed both collagen and elastin f normalities by electron microscopy. Cultured fibroblasts 
hom both patients produced 2 - 8 times more tropoelastin 
t an normal skin fibroblasts in the presence of 10% calf 
serum. Involved skin fibroblasts of one patient produced up 
tkelght times normal levels, whereas apparently uninvolved 
S In Was also elevated more than threefold. In a second pa-
tIent, whose involvement was nearly complete, elastin pro-
duction was high in involved areas and less so in completely 
involved skin. Transforming growth factor-p1 (TGFP1), a 
powerful stimulus for elastin production, brought about simi-
lar relative increases in normal and BOS strains. Basic fibro-
blast growth factor, an antagonist ofTGFp1-stimulated elas-
tin production, was able to reduce elastin production in basal 
and TGFpl stimulated BOS strains. Elastin mRNA levels 
were elevated in all patient strains, suggesting that Buschke-
Ollendorff syndrome may result, at least in part, from abnor-
mal regulation of extracellular matrix metabolism that leads 
to increased steady-state levels of elastin mRNA and elastin 
accumulation in the dermis.] Invest DermatoI99:129-137, 
1992 
----------------------------------------------------------------------------------------------------
B uschke and Ollendorff first made the association be-tween an asymptomatic spotting of bones (osteopoiki-los is) and connective-tissue nevi (dermatofibrosis len-ticularis disseminata) in 1928 [1], although both had been described previously [2,3]. Over 130 cases and 
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AbbreViations· 
~~F: basic 'fibroblast growth factor 
ED S: Buschke-Ollendorff syndrome 
E S: Ehlers Danlos syndromes F~~SA: enzyme-linked immunosorbent assay 
M. : fetal calf serum 
N~PS: 3-N-morpholinopropanesulfonic acid 
SLE~S: newborn calf serum 
SSC~ systemIC lupus erythematosus . 
SSPE O.15M NaCl In 15 mM sodIUm CItrate, pH 6.8 
1'GFp: 0.18M NaCI, 10 mM NaPO., pH 7.7, 1 mM EDTA 
1: transforming growth factor-pI 
numerous pedigrees have been reported, establishing the BOS as an 
autosomal dominant disease with high penetrance, variable expres-
sion, and an incidence of 1 in 20,000 [4-13] . The basic defect is 
unknown, although structural abnormalities of elastic fibers, the 
microfibrillar component, and the collagen fibrils have been re-
ported [11,14,15] . Using estimates of desmosine content and digital 
morphometric analysis of stained biopsies, Uitto et al demonstrated 
elevated elastin accumulation in involved skin relative to unin-
volved s~in and to skin of controls [16]. More recently, preliminary 
data on 1I1creased elast1l1 gene expression has been reported [17]. 
Other dermatologic manifestations reported in association with 
BOS suggest that there is also an effect on collagenous tissues. 
Findings include Dupuytren's contractures and Peyronie's Disease, 
oral fibromas, keloids, histiocytomas, knuckle pads, fibrokeratomas 
and keratoderma palmoplantare striae, anetoderma, morphea, and 
scleroderma [11]. Skeletal anomalies including exostoses, enchon-
dromas, osteofibromas, osteopetrosis, melorheostosis, arthritis, and 
short stature have also been reported [11] . 
In the present study, we sought to determine whether altered 
elastin. accumulation was a stab.le mar~er of the disease phenotype in 
the sk1l1 fibroblasts of two patients With BOS by correlating ultra-
structural and biochemical observations. We have also evaluated 
one possible site of abnormal regulation, the response to the cyto-
kines TGFfil and bFGF. 
CASE HISTORIES 
Case 1 A 58-year-old white man was evaluated in November 
1985. 
At age 28, after routine X-ray for evaluation of stiff joints, patient 
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Figure L Pedigrees ot Buschke-Ollendorf Syndrome families. Squares, 
male; circles, female; dots, miscarriage; diagonal lines, deceased. The clinical 
features are denoted by the filling of the four quadrants shown in the right 
corner of the drawings. Osteopoikilosis is based on radiographic confirma-
tion. Asterisks in A denote hyperextensive joints. A: Pedigree of case 1 
fami ly. The proband (III 2) had BOS with stiff joints and ichthyosis vulgaris. 
His mother (II 8), two brothers (III 5, III 6), a daughter (IV 1), a son (IV 2), 
and a nephew (IV 7) were similarly affected with dermatofibrosis lenticu-
laris. X-rays were only avai lable for the proband and his children, so the 
diagnosis of the osteopoikilosis (lower lljt quadratll) was unknown in the 
others with skin findings. All adults with BOS had stiff joints (upper right 
comer). Ichthyosis vulgaris (lower right quadrant) was present in the proband, 
in his daughter (IV 1), and a niece (IV 6) who did not have BOS. Several 
uncles (II 2-6), a son (IV 3), and a niece (IV 6) had joint hypermobility 
(asterisk) not associated with BOS. B: Pedigree of case 2 family. The proband 
(III 3) had BOS (lift quadrants), mixed connective tissue disease (lower right 
quadrant), and arth ritis (upper right quadrant). Her father (II 2), two of his 
brothers (II 3 and II 4), one of her sisters (III 4), and a niece (IV 5) were also 
affected with BOS. Connective tissue diseases were present in the father (II 
2; glomerulonephritis due to SLE), one of his brothers (II 3; rheumatoid 
arthritis), and the proband (III 3; mixed connective tissue disease). The 
proband's sister (III 2) also had rheumatoid arthritis and a positive antinu-
clear antibody. Additionally, there was a very strong family history of de-
generative arthritis in the proband's paternal grandmother, grandfather, 
uncles, and sister (upper right quadrant). 
1 was diagnosed as having osteopoikilosis. He and several family 
members (Fig 1A) had noticed small , yellowish papules and nodules 
on the skin since chi ldhood, accompanied by prominent joint stiff-
ness, especially affecting the ankles and shoulders. Other family 
members, however, had loose joints and some had ichthyosis vul-
garis, not associated with BOS. The patient had a past history of 
Behcet's disease, migraine headaches, hypertension, and hoarseness. 
Physical examination revealed a middle-aged, hoarse man with 
thousands of 1-2 mm yellow papules prominent on volar wrists, 
inner arms, and legs (Fig 2A) sparing face and neck. There were firm 
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1-2 cm fibrous nodules on the trunk, a 1 X 3 cm firm, brow 
connective tissue nevus on the buttocks, and a lOX 10 cm ellipti ni n~vus. spilus o.n the left flank. T~1e shins were xerotic, consist~~t 
WIth IchthyOSIS vulgans . He had II1Jected sclerae and conjunctiva 
Firm 4-5 mm flesh colored papules were present on the tongue an~ 
laryngoscopy showed leukoplakia. Joint mobi lity was limited in th 
ankles with no plantar flexion possible past 95 0 , and near lack ~ 
inversion and eversion. Shoulders could not be abducted beYO:d 
Figure 2_ Gross appearance and histology of BOS lesions. A: Photograph 
showmg gross appearance of the skll1 over the knee from case 1 (biopsy site) 
WIth 1-2 mm yellOWIsh papules also seen over the forearms, volar wrists, 
and thighs, consistent with dermatofibrosis lenticu laris disseminata. B: 
Biopsy of a dermal nodule from knee of patient 1 examined by light micros-
copy and Verhoeff-van Gieson stain (magnification X 15) shows a subtle 
dermal nodule (arrows) of thickened collagen and clastic fibers. C: High-
power view (magnification X 30) of the nodule and surrounding normal skin 
showing thickened collagen fibers (opelled arrow) and increased clastic fibers 
(arrowhead). Adjacent normal dermis is present in the other half of the 
photomicrograph (solid arrOIll, collagen fiber of normal thickness). 
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90 °, and internal and external rotation were moderately restricted. 
Both wrists lacked fu ll fl exion and extension, and all fingers could 
not be full y extended by active and passive manipulation. 
Laboratory evaluation included complete blood count with 
10,300 white cells, 49.9 hematocrit, and 307,000 platelets. Electro-
lytes, thyroid function, prothrombin time, partial prothrombin 
time, and multichanne l chemistry analysis were normal (except a 
serum glutamic pyruvic transaminase of 73) . 
Case 2 A 45-year-old fema le previously diagnosed and reported 
to have BOS [13] was evaluated. Beginning at age 3, in 1945, she 
experienced severe pain in the feet and was diagnosed with osteo-
poikilosis by X-ray. At age 15 the patient developed arthritis. In 
1981 she developed a facial rash that had histology consistent with 
systemic lupus erythematosus. Anti-nucl ear antibody and rheuma-
toid factor were detected in 1982. In 1983 she developed pericardi-
tis and in April 1987 she had a muscle biopsy consistent with poly-
myositis. In December 1987, she complained of several months of 
dry eyes, mouth , and vagina and of severe proximal muscle weak-
ness. She was taking 25 mg of prednisone alternating with 30 mg 
every other day and 30 mg per week of methotrexate. She was on 14 
units NPH insulin for steroid-induced diabetes. 
Osteopoikilosis was present in the patient 'S father, two of his 
brothers, one of her sisters, and a niece by the affected sister (Fig IB) . 
Her father had died with glomerulonephritis secondary to systemic 
lupus erythematosus. One of her father's affected brothers had 
rheumatoid arthritis. One of her sisters had BOS and one had rheu-
matoid arthritis with a positive antinuclear antibody. Many family 
members had degenerative arthritis. 
On physical examination this was a moderately obese female with 
generalized alopecia. The parotid glands were slightly enlarged a~d 
tender. There was an intention tremor and 4/5 muscle strength 111 
neck flexion and in the deltoids, triceps, biceps, iliopsoas, and quad-
riceps muscles. There was limited joint mobility, especially of the 
neck, shoulders, hips, and lower back. On skin exam there were 
multiple, 1-2 mm, yellow, pearly papules over the volar wrists, 
arms, and legs. The lesions were confluent in many areas, leaving no 
clinically uninvolved skin. 
Pertinent laboratory data included a normal complete blood 
count, chemistries, and creatine phosphokinase, anti-nuclear anti-
body, and C3 and C4 components of complement. Glucose, choles-
terol, and triglycerides were slightly elevated. The patient was felt 
to have an overlap connective tissue disease with Sjogren's syn-
drome, polymyositis and lupus. In August 1988 (age 46) the pro-
band noted increasing numbers of yellow papules such that they 
. became confluent in most areas, and she complained of increased 
pain in the knees and shoulders. Skin biopsies were taken from 
involved and most-involved skin of the arms. There was such exten-
sive involvement that it was not possible to find totall y uninvolved 
skin. 
MATERIALS AND METHODS 
Skin Biopsies The patients signed consent forms for all studies. 
Punch biopsies of skin were obtained with lidocaine anesthesia from 
most involved , involved, or uninvolved skin on the leg. The bIOp-
sies were split for explant culture and electron microscopy. A nodu.le 
with surrounding normal skin was excised for routine hematoxylm 
and eosin and elastin staining (Verhoeff-van Gieson). 
Light and Electron Microscopy The skin was fixed in half-
strength Karnovsky's fixative at 4°C for at least 24 h [18] . The tissue 
was stained en bloc with 1 % OS04' dehydrated through graded 
alcohols, infiltrated with propylene oxide, and embedded in epon 
[19]. Sections 1 J1 thick were stained according to Richardson et al 
[20] and examined by light microscopy using a Zeiss photomicro-
scope. Thin sections were collected onto copper grIds, stamed With 
1 % phosphotungstic acid, 1 % uranyl acetate, and lead citrate (21), 
and viewed with a Phillips 420 scanning transmission electron mi-
croscope. 
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Fibroblast Cultures Biopsies were explanted under cover slips 
in Dulbecco's modified Eagle's medium containing 10% bovine calf 
serum (Gibco Laboratories, Grand Island , NY), and 1 X antibiotics 
(penicillin-streptomycin-fungizone; 100 X, Gibco). Normal skin fi-
broblasts (GM 4390, age 23), used as controls, were obtained from 
the National Institute of General Medical Sciences (Coriell Insti-
tute, Camden, NJ), Fibroblasts were grown in Dulbecco's modified 
Eagle's medium containing 10% fetal calf serum (Hyclone, Logan, 
UT) in an atmosphere containing 5% CO2-humidified air until 
confluent and passed 1: 3 using 0.025% trypsin-O.02% EDT A 
(Sigma, St. Louis, MO). Cells were used prior to signs of cellular 
senescence, between passages 4 and 8, during which time elastin 
production was stable. For collection of culture supernatants for 
elastin analysis, the serum was switched to newborn calf serum 
(Hyclone, Logan, UT) at confluence to reduce assay background, 
and tropoelastin accumulation was assayed in the medium after 
2-3 d. 
Cytokine Treatment Recombinant human TGFpl was pro-
vided by Genentech, (South San Francisco, CA); recombinant 
human bFGF was provided by Synergen (Boulder, CO). Affected 
and normal human skin fibroblasts in passages 7 and 8 were grown 
to pre-confluency in 35-mm dishes. Fresh medium containing 10% 
NBCS, antibiotics, and the desired amount ofTGFpl (from 0 to 7.5 
ng/ml) was added to duplicate dishes. In another set of experiments, 
cells were subcultivated to culture-chamber slides (Lab-Tek, Nunc, 
Narerville, IL) and exposed for 48 h to TGFpl (0,0.1,1.0, and 10.0 
ngjml) alone or combined with 100-ng/ml ofbFGF. Medium and 
cells for elastin and DNA quantitation were harves ted after 48 hand 
stored at -20°C for a few days, until assays were performed. 
DNA Assay Cell monolayers were washed twice with cold PBS 
and then treated with 1.0 ml (0.5 ml in the case of chamber slides) of 
10 mM EDTA, pH 12.3. Cell number was evaluated by a f1uorime-
tric procedure using Hoechst 33258 (Boehringer-Mannheim, India-
napolis, IN) as previously described [22]. 
Elastin ELISA Assay A standard enzyme-linked immunoabsor-
bent assay (ELISA) for elastin was used as previously described [23]. 
To make the assay specific for human elastin epitopes, rabbit anti-
serum to pig a-elastin was used at a 1 : 3000 dilution on plates coated 
with 40 ng of human a-elastin. The test was made specific for 
tropoelastin by using 85 pg to 11 ng of porcine tropoelastin as the 
competing antigen in a standard curve. Results from sister cultures 
at three dilutions of culture medium (n = 6) were expressed as 
human elastin molecular equivalents produced per cell per hour 
after correction for the background present in serum-containing 
medium. 
Elastin mRNA Studies To assess the status of elas tin gene tran-
script levels in this disease, hybridization studies were performed 
with poly[A]+-mRNA isolated from the BaS strains and compared 
to elastin mRNA levels in the normal strain that produced 30.8 ± 
1.6 X 103 molecular equivalents of elas tin per cell· h. Specificity 
was confirmed by Northern hybridization (Fig 8A). 
RNA Isolation Messenger RNA was extracted from cells by pre-
paring celllysates in an adaptation of the SDS-proteinase K method 
described by Pihlajaniemi and Myers [24]. Yields were equivalent 
for all strains. The concentration of NaCl in the cell lysates was 
increased to 100 mM, and the samples were heat-denatured at 70°C 
before passing through a poly[U]-sepharose column (Sigma, St. 
Louis, MO) five times. The column (1 g of dry material) was 
washed with NETS buffer (100 mM NaCl , 10 mM Tris-HCl, pH 
7.5, 1 mM EDTA, 0.2% SDS) until the OD260 was zero, and then 
eluted with 3 ml of elution buffer (10 mM Tris-HCl, pH 7.5,1 mM 
EDTA, 0.2% SDS, 90% formamide). Peak fractions containing 
poly [A]+-mRNA were pooled, ethanol-precipitated, and resus-
pended in sterile water at 150 J1g/ ml. 
RNA Hybridization Studies After boiling in water for 5 min or 
after treating with 6.5% formaldehyde solution at 65°C for 10 min, 
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Figure 3. Transmission electron micrographs of skin from a patient with BOS (case 1). A: The clastic fibers (E) were abundant relative to the amount of 
dermal collagen (C). In some areas the elastic fibers had frayed edges but fairly normal proportions of microfibrils and amorphous elastin. Bar, 21J.. B: In other 
areas, the elastic fibers appeared more matted and tangled, and they lacked the regular deposition of microfibrils within the elastin matrix. Bar, 1 IJ. . C -E: 
Transmission electron micrographs of collagen from involved (C,D) and uninvolved (E) skin arc shown. Composite collagen fibrils (C, arrows; bar, 0.51J.) were 
present among normal fibrils in involved skin. Large collagen fibers appeared to be made up of parallel cords of smaller fibers (D; bar,S II). A similar cordlike 
organ ization of collagen fibers was present in the papillary dermis of uninvolved skin (E: bar, 21J.). Magnification: (A) X 5400, (B) X 11,400, (C) X 24,000, (D) 
X3300, (E) X7400. 
mRNA was applied to Zeta Bind nylon membrane filters (AMF 
C uno, Meriden, Connecticut) in a vacuum manifold with circular 
orifices (Schleicher and SchueH, Keene, NH) and baked at 80°C in 
vacuo for 2 h. N orthern blots were run in 1 % agarose gels contain-
ing 6.5% formaldehyde in MOPS buffer [25] and then capillary-
blotted onto membranes using 6 X SSe. Filters were baked in vacuo 
at 80 °e. The presence of elastin mRNA on filters was detected with 
a 1.1 -kb DNA restriction enzyme fragment isolated from a human 
elastin cD NA clone CHE-4 [26]' by Bam HI and HindIII digestion, 
agarose gel electrophoresis, and electroelution . This fragment in-
cludes about half of the coding region of the elastin mRNA mole-
cule, including exons 18 through 36, as well as 26a but lacki ng the 
3' -untranslated region. DNA was subsequently labeled with [32P]_ 
dCTP by random priming [27,28] according to manufacturer's in-
structions (Pharmacia LKB Biotechnology, Piscataway, NJ) . The 
clone OS, a cDNA for cytochrome C oxidase subunit II, was used as 
a constitutive probe* to normalize for mRNA recovery. Prehybridi-
zation (4-12 h) and hybridization (18-20 h) were carried out at 
42 °C in 1.5 X SSPE (0 .18 M NaCl, 10 mM N aP04 , pH 7.7,1 mM 
EDTA) [25] , 10% nonfat dry milk, 2% SDS, 10% dextran sulphate, 
50% formamide, and 420 ,ug/ml of salmon sperm DNA. Final 
stringency washes were in 0.1 X SSC, 0.1 % SDS, 65 ° e. Blots were 
exposed to pre-flashed film (Kodak X-Omat AR, Kodak, Roches-
ter, NY) at -70°e. 
Autoradiographs were scanned with a Bio-Rad 6520 video densi-
tometer, and the output was recorded and integrated using MS-
• Matrisian L (personal communication). 
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Figure 4. Transmission electron micrographs of involved (A) and most-involved (B) skin from case 2. ~esions were nearly confluent in th is patient. In the 
involved skin (A), the elastic fibers (E) were abundant relative to normal appeanng collagen (C). The elastic fibers were frayed around the edges and had holes 
within the clastic matrix. Bar, 21./. In most-involved dermis (B), there vere dense networks of elastin matrix (E) With proteoglycan-ltke matrix 111 between 
(arrowheads) . Many of the adjacent .colla.gen fibrils (C) were abnormal. Cells reta ined a filamentous material within the cisternae of the rough endoplasmic 
reticulum (arrows). Bar, 21./. Magl1lficatlOn: (A) X 5400, (B) X 8200. 
DOS based software (Bio-Rad, Richmond, CA) . Data were com-
pared among dots showing a linear response to several dilutions. 
Analysis of Elastin Gene Polymorphism by South~rn Blott-
ing Genomic DNA from fibroblasts was prepared usmg a stan-
dard SDS-proteinase K extraction procedure [29) . Ten micrograms 
of DNA per lane was digested with Eco RI, Msp I, Pst I, Taq 1, and 
Hinf II (Bethesda Research Laboratories, Gaithersburg , MD) at 4 
units/{lg DNA in the manu fac turer's recommended digestIOn 
buffers. The DNA was electrophoresed on 0.8% agarose gels and 
transferred to Zeta Bind membranes for standard Southern hybrid-
ization [30) as per the manufacturer's conditions. 
DNA from a sheep elastin genomic probe (pSE1-1.3) [31) and the 
human cDNA probe (CHE-4 [26)) were labeled to 1 X 109 cpm/{lg 
using a random primer oligo-labeling kit (Boehringer Mannheim 
. Biochemicals) with [32P)_dCTP (Amersham) [27,28) . Hybndlza-
tion was at 42 °C for 24 h in 50% formamide, 5 X SSC, 1 X 
Denhardt's, 100 {lg/ml herrin g sperm DNA, and 1 % SDS. Washes 
were done at room temperature in 2 X SSC, 0.5% SDS, and at 60 °C 
in 2 X SSC, 0.1% SDS. 
RESULTS 
Histology and Electron Microscopy A biopsy taken from a 
nodule and surrou nding normal skin (case 1, Fig 2A) showed com-
pact and large collagen bundles in the center of the nodu le com-
pared to normal surrounding areas of the dermis (Fig 2B). Verhoeff-
van Gieson stain for elastic fib ers showed increased numbers of 
thickened elastin fibers in the lesion (Fig 2C). 
Biopsies from yellow papules and so-called normal skin were 
examined by transmission electron microscopy. In case 1, the in-
volved dermis had clumps of irregularly shaped elastic fibers with 
frayed edges (Fig 3A) . Other areas of the lesion ex hibited a dispro-
portionately high content of amorphous elastin re lative to microfi-
brils (Fig 3B) . Composite collagen fibrils (Fig 3C) were present in 
collagen fibers adjacent to abnormal elas tic fib ers. Large collagen 
fibers containing fibrils with normal cross-sections appeared to have 
been assembled from smaller cordlike fibers (Fig 3D). This unusual 
organization of cords of collagen fibers was also present in the 
papillary zones of uninvolved skin (Fig 3E) . 
Elas tic fibers were relatively overabundant in case 2, but the biop-
sies from the involved (Fig 4A) and the most involved skin (Fig 4B) 
showed several differences . The elastic fibers in involved skin (Fig 
4A) were frayed around the edges, contained abundant electron-
dense material and had holes within the elastic matrix. The most 
involved dermis (Fig 4B) showed disproportionately high amounts 
of amorphous, electron-lucent elastin (E) re lative to collagen (C) . 
There were pools of ground substance and proteoglycans surround-
ing the elastic fibers and pools of fibrill ar material within swollen 
cisternae of the rough endoplasmic reticulum. Adjacent coll agen 
fibers had fibrils with irregu lar cross-sectional contours. 
The degree of skin involvement differed in the two cases. In case 
1, biopsies could be made from apparently uninvolved and involved 
sites. In contrast, in case 2, the near confluent state of the lesions 
made it difficult to obtain completely uninvolved dermis; more-
over, the most involved areas showed further degeneration of nor-
mal fibrous architecture as wel l as fibroblasts with swollen endo-
plasmic reticulum. 
Elastin Production and Cytokine Response Elastin produc-
tion levels in a normal skin fibroblast stra in were compared with 
production levels in uninvolved and invo lved skin fibroblasts from 
case 1 (Fig 5,first columll) or involved and most involved skin from 
case 2 (Fig 6, first columll). Because of the extensive involvement 
found in case 2, fib roblasts from completely uninvolved dermis 
were unavailable. In the most involved area, the histopathology was 
so severe that few normal fibroblasts or connective tissue were 
present. Thus, cells taken from the most involved areas may have 
represented end-stage lesions. Expression of elastin in the presence 
of 10% NBCS was about 7 - 8 times higher than control levels in 
involved BaS cells of case 1; in addition, uninvo lved fibroblasts of 
case 1 were also about three times as active as the control strain in 
accumulating soluble elastin in the cu lture medium. Elastin accu-
mu lation was also markedly elevated in cell s from the involved areas 
of case 2, whereas in the most involved lesions of case 2, production 
was only doubled. 
To determine whether increased elastin production may have 
been due to altered responsiveness to an elastogenic effector TGFpl, 
the cytokine was added to BaS cultures. Elastin production was 
stimulated in all BOS sk in fibrobl as ts as well as dermal cells from a 
normal donor (Fig 5). Production was stimulated more than two-
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Figure 5. Elastin production in fibroblasts of a BOS patient (case 1) and 
effect of increasing concentrations of recombinant human TGF/11. Data on 
cel lular production was obtained in low-passage (p6- p8) cultures. Ordinate: 
elastin production in molecular equivalents per cell . h. Normal values 
(solid bars) are represented by strain GM 4390 (age 23) also used as a reference 
source of elastin mRNA. Hatched bars, uninvolved skin: shaded bars, involved 
skin. Data was obtained in passage 6-8 cultures. TGFJll (0 to 7.5 ng/ml) 
was added immediately before confluency to cultures in 35-mm culture 
dishes in the presence 0["10% NBCS and antibiotics. Media were harvested 
48 h later. Elastin production was expressed as molecular equivalents per 
cell· hour, ±SD. Our unpublished studies have shown that little, if any, 
newly synthesized elastin remains in the cell layer, and analysis of this 
compartment was omitted from the present study. 
fo ld in both cell strains from BOS case 1 and more than threefold in 
normal cells. In case 2 (Fig 6), involved lesions exhibited highest 
basal and TGF/H-stimulated levels of elastin production, whereas 
most involved skin fibrobl as ts w ere not as responsive to TGFpl 
stimul ation . 
Because bFGF is known to an tagonize the effect of TGFpl on 
elastin production [32], cells were treated w ith bFGF at a concentra-
tion that inhibits TGFpl effects in normal fibroblasts and smooth 
muscle cells [3 2] (100 ngjml) and increasing concentrations of 
TGFpl (0 -10 ngjml). Basal levels of elastin production in this 
strain of BOS fibroblasts (involved, case 1) were reduced by 85% 
with 100 ngjml ofbFGF (Fi g 7) . Although addition ofl0 ngjml of 
TGFpl induced a nearly six fold rise in elastin production, bFGF 
treatment reduced this parameter by a factor of 12.5, to 47% of basal 
production level. 
Analysis of Elastin mRNA Levels Messenger RNA levels w ere 
quantified in two ways (Table I): by densitometry of either N orth-
ern blots (Fig 8A) or dot blots (Fig 8B), hybridized with either 
C HE-4, a human elastin cDNA probe [26] or D5, a constitutively 
expressed, mitochondrial gene product [33] (Fig 8e). The raw den-
sitometric data gave clear evidence of increased steady-state levels of 
elas tin transcripts in BOS cells relative to a normal fibroblast strain; 
moreover, correction for mRNA recovery showed that the invo lved 
cells (case 1) had about a fivefold relative increase in elastin mRNA 
content (Table I) . Although Northern hybridization showed little 
relative increase in elastin mRNA from uninvolved fibroblasts of 
case 1, about a 70% increase was measured by the more quantitative 
blot hybridization procedure in w hich efficiency of transfer and 
binding is uniform and high. 
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Figure 6. Effect of increasing concentration of TGF/11 on elastin produc-
tion in cultured fibroblasts from a BOS patient (case 2) and normal skin 
fibroblasts. Control strain was GM4390 (solid bars) . Shaded bars, involved 
skin; cross-hatched bars, most-involved skin; TGF/11 (0; 5.0; 7.5 ng/ml) was 
added immediately before confluency to 3S-mm dishes. Media was har-
vested after 48 h. Elastin production was expressed as molecular equivalents 
per cell · h, ±SD. 
Analysis of Elastin Gene by Southern Blotting Compared to 
normal fibroblast DNA, no differences in restriction patterns were 
noted in BOS fibroblast DNA with any of the enzymes tested, and 
no restriction fragment length polymorphisms that would be useful 
for linkage studies were identified for the elas tin gene (data not 
shown). 
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Figure 7. Basal and TGF/11-stimulated elas tin production in cultured BOS 
skin fibrobl asts is inhibited by bFGF. Involved fibroblasts from case 1 were 
subcultivated in culture-chamber slides and exposed for 48 h to TGF/11 
(0 - 10.0 ng/ml in DMEM, antibiotics, and 10% NBCS) alone (shaded bars) 
or combined with 100 ng/ml bFGF (hatched bars). Elastin production is 
expressed as percent of control (10% serum only), ±SD. 
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Figure 8. Detection and quantification of elastin mRNA in normal and 
BOS fibroblasts. A: Northern blot hybridization of RNA to CHE-4, a 
human elastin eDNA probe, labeled with [32P]_dCTP as described in Materi-
als and Methods. Lal1e 1, 10 /lg total RNA from sheep nuchal ligament, used as 
a marker and positive control; lane 2, poly[AJ+-mRNA (0.75 /lg) from GM 
4390 as the normal fibroblast strain; lane 3, poly[A]+-mRNA from unin-
volved BOS fibroblasts of case 1 (0.75 /l g); lalle 4, poly[A)+-mRNA from 
involved BOS fibroblasts of case 1 (0.75 /l g). B: Dot hybridization of twofold 
dilutions of RNA samples (beginning at 250 ng) corresponding to lanes 2-4 
of A. Loading of RNA was normalized by reh ybridization of the Northern 
blot with a probe for D5, a constitutively expressed mitochondrial gene, 
after stripping the original probe with 96% formamide at 65 °C (2X). C: 
Constitutive express ion is shown by the D5-generated signal of each of the 
samples in A. Responses in lanes 2-4 were quantified by densi tometry and 
used to correct the hybridization data of A and B, as shown in Table 1. 
DISCUSSION 
The cultured dermal fib roblas ts from two patients with BOS 
showed increased elastin production and elastin mRNA levels con-
sistent with a phenotype of abnormal elastogenesis. This effect 
could not be attributed to increased sensitivity to the cytokine, 
TGFp1 , and elevated elastin production was reduced by treatment 
of cells with another cytokine, bFGF. Although the genetic defect 
in BOS could be co nstitutive overproduction of elastin, the time of 
onset of elastosis, changes in bone, and the initial, focal nature of the 
lesions suggest that other factors influence the expression of this 
pleiomorphic defect. 
The BOS in these patients presented a complex phenotypic back-
ground , possibly indicating the contribution of multiple (generic) 
fac tors. In addition to the dermatofibrosis lenticularis disseminata 
characteristic of BOS, patient 1 and family members also had large 
plaque-like connective tissue nevi, and dermatofibromas. The pa-
tient had a nevus spilus, considered to be a fo rme fru ste of neurofibro-
matosis. Von Recklinghausen's neurofibromatosis is also character-
ized by fibrou s tumors in skin and bone [34] inheri ted in an 
autosomal dominant pattern with variable penetrance. This dis-
order has recently been linked to th e pericentric region of 17q12 -
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22 in humans [35] and mutations have been described [36] and 
mapped [37], but linkage analysis of BOS is not yet available. 
Hinrichs et al have inserted the tat region of the human T-cell 
retrovirus, HTL V -1 , into transgenic mice to create a neurofibroma-
tosis phenotype that was then passed through three generations 
[38] . A retrovirus affecting skin and/or bone fibroblas ts could con-
ceivably explain the heterogeneity of skin and joint involvement of 
BOS, the altered matrix regulation, and the autosomal dominance 
inheritance pattern. 
The regulation of the connective tissue matrix is extremely com-
plex, and the interrelationships among the genes for matrix proteins 
and proteglycans are not fully understood. Abnormalities of one 
matrix component may affect the structural organization of another 
[14] . Elastin and collagen are fibrobl as t products that can be inter-
woven in various proportions to determine the biomechanical prop-
erties of an extracellular matrix. Disproportionate synthesis or accu-
mulation of elas tic tissue components may act to disrupt delicate 
feedback regulatory systems that play a role in the formation of 
normal matrix. 
Patients with BOS had ultras tructural abnormalities of both col-
lagen and elastic fibers. The elastic fiber changes, however, were 
much more pronounced. Studies of cell strains derived from differ-
ent biopsy sites in vitro revealed obvious increases in elas tin produc-
tion under standard culture conditions. Collagen production, al-
though not systematically examined, was variably lower in BOS 
strains, t possibly contributing to the presence of composite colla-
gen fibrils in both patients, a feature also seen in EDS and other 
disorders of connective tissue [14] . Changes in collagen production 
may have been secondary to elastin overproduction, the consistent 
feature of the BOS phenotype. The fibrobl asts explanted from af-
fected skin produced a five to eightfold excess of tropoelas tin rela-
tive to controls, uninvolved fibroblas ts (case 1) produced a two to 
threefold excess, and elastin mRNA levels were likewise elevated. 
However, mRNA levels may not have fully accounted for the in-
creases in elastin accumulation, because the apparent increase in 
protein accumulation was somewhat higher than mRNA increases. 
Turnover of newly synthesized tropoelastin or efficiency of mRNA 
utilization could be playing a role in this defect. Southern blotting 
data of case 1 have fail ed to show a gross structural rearrangement of 
the elastin gene, but we cannot exclude the elastin gene as being one 
target of a structural mutation. Restriction fragment length poly-
morphisms, rare in the elastin gene f39], have not been informative 
in these families to date. A newly discovered polymorphism may be 
more informative [40] . 
Regulation of elastin production is governed by many environ-
mental factors, including the matrix per se [41], glucocorticoids 
[42] , and growth factors [43,44] . The pleiotropic phenotype ofBOS 
could result from the derangement of a common control or signal 
mechanism such as cellular receptor or a signal-transduction path-
way, one of the consequences being elevated cutaneous elastin gene 
expression. Other elas tic tissues such as lung and aorta are not 
known to be involved in this syndrome. It is conceivable that ex-
pression is driven by factors from the epidermis or the cutaneous 
environment. Elastin production in vitro is dependent on the serum 
concentration [45], which implies that cytokines released at injury 
sites are involved in regulation of elastin production. This dominant 
disorder could represent derangement of a serum-responsive regula-
tory mechanism operant in skin, rather than a defect in the elastin 
gene itself. Although BOS cells appeared more sensitive to TGFpl 
in preliminary experiments, this was a variable feature . Defective 
regu lation may be more consistent with the very generalized con-
nective tissue defects seen in these patients. Even if the primary 
genetic lesion is not in the elastin gene, the present findings show 
altered elastogenesis to be a highly significant biochemical marker 
that may help to unravel the actual basis of this genetic defect. 
t Duvic M (unpublished findings). 
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Table I. Relative Elastin mRNA and Protein Levels in Buschke-Ollendorff Fibroblasts 
Cell Strain 
Case 1 involved 
Case 1 uninvolved 
Case 2 involved 
GM 4390! 
Northern' 
1.95 
1.30 
6.64 
1.00 
Ratio' 
Dot Blot' OS! 
2.63 0.46 
2.22 1.32 
NO 0.53 
1.00 1.00 
Corrected Ratiob 
Northern/OS Dot Blot/OS Protein' 
4.23 5.70 7.8 
0.99 1.68 2.8 
12.53 NO 3.2 
1.00 1.00 1.0 
• Densitometric scans of Northern and dot-blot data from equivalent amounts of RNA arc expressed relative to signals from control strain, GM 4390. Although A'60 values We 
equal, densitometry of 05 hybridization sbowed substantial differences in actual concentrations of mRNA. re 
, Uncorrected ratios from the preceding columns were divided by the ratio of 05 signal to correct for differences in the amount of mRNA present in samples from each str . 
, Data derived from ELISA assay shown in Figs 5 and 6. 'In. 
J Densitometric data from Northern hybridization to DNA from the elastin probe CHE-4, expressed relative to the control strain, GM 4390. 
, Densitomet~ic data from serial dilution of cytoplasmic mRNA hybridized to CHE-4, representing the mean of ratios from three serial dilutions of mRNA giving a linear 
dose-response Signal. 
J Derived from Northern blot hybridization to a constitutively expressed human gene recognjzed by plasmid 0-5. 
I Control strain, elastin production = 30.8 ± 1.6 X 10' molecular equivalents/cell · h. 
We wisl. to t/rank B.G. Roulltree, M.D.Jor tl.e referral oj tl.e two patients; Yvette 
Craujord, Dave Wilsoll and Omelia Zoia Jor technical assistatlce; alld Jeanette 
Quimby Jor preparation oj this matJJlscript. 
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